June 17th 2025
Chrysalis lists among its partners early-stage biotechnology companies, contract research organizations, top-10 pharmaceutical firms, and various other life sciences stakeholders.
BeiGene Selects GE Healthcare’s Biologics Factory to Boost its Manufacturing Capacity
September 20th 2018BeiGene is set to build late-stage clinical and commercial production capacity for cancer monoclonal antibodies with GE Healthcare’s KUBio, the prefabricated biopharma facility based on single-use technologies.